Clinical trial

Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer

NCT00167648

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-03-01

PhasePHASE2

Study timeline

Study start (unknown)2005-03-01Date precision: month

Registry last updated2009-01-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancerunresolved

Prostate Neoplasmsunresolved

Interventions

Leuprolide or goserelinDRUG

Transdermal estradiolDRUG

Sponsors & collaborators

University of Washingtonlead sponsor

Pacific Northwest SPOREcollaborator

Mapped research locations

SeattleWashington, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00167648 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.